Enanta Pharmaceuticals (ENTA) Long-Term Deferred Tax (2014 - 2021)
Enanta Pharmaceuticals' (ENTA) quarterly Long-Term Deferred Tax came in at $345000.0 in Q2 2021, down 97.74% YoY from $15.3 million in Q2 2020, and little changed on a QoQ basis from $345000.0 in Q1 2021.
Enanta Pharmaceuticals (ENTA) Long-Term Deferred Tax (2014 - 2021) Analysis & Trends
Enanta Pharmaceuticals (ENTA) has 8 years of Long-Term Deferred Tax data on file, last reported at $345000.0 in Q2 2021.
- Quarterly Long-Term Deferred Tax fell 97.74% year-over-year to $345000.0 in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $345000.0 (down 97.74% YoY) and the FY2020 annual result came in at $345000.0, down 96.96% from the prior year.
- Long-Term Deferred Tax steadied at $345000.0 in Q2 2021, from $345000.0 in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $17.7 million in Q2 2017 to a low of $345000.0 in Q3 2020.
- A 5-year average of $8.5 million and a median of $9.2 million in 2018 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2017 — Long-Term Deferred Tax jumped 203.32% — and 2021, when it sank 97.74%.
- Tracing ENTA's Long-Term Deferred Tax over 5 years: stood at $7.6 million in 2017, then climbed by 22.2% to $9.2 million in 2018, then gained by 15.22% to $10.7 million in 2019, then sank by 96.76% to $345000.0 in 2020, then changed by 0.0% to $345000.0 in 2021.
- The last three Long-Term Deferred Tax figures came in at $345000.0 (Q2 2021), $345000.0 (Q1 2021), and $345000.0 (Q4 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Enanta Pharmaceuticals | 383.29 Mn | 193.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 345,000.00 |
| Mar 31, 2021 | 345,000.00 |
| Dec 31, 2020 | 345,000.00 |
| Sep 30, 2020 | 345,000.00 |
| Jun 30, 2020 | 15.29 Mn |
| Mar 31, 2020 | 12.42 Mn |
| Dec 31, 2019 | 10.66 Mn |
| Sep 30, 2019 | 11.34 Mn |
| Jun 30, 2019 | 10.15 Mn |
| Mar 31, 2019 | 9.05 Mn |
| Dec 31, 2018 | 9.25 Mn |
| Sep 30, 2018 | 8.38 Mn |
| Jun 30, 2018 | 7.93 Mn |
| Mar 31, 2018 | 7.57 Mn |
| Dec 31, 2017 | 7.57 Mn |
| Sep 30, 2017 | 10.12 Mn |
| Jun 30, 2017 | 17.72 Mn |
| Mar 31, 2017 | 13.90 Mn |
| Dec 31, 2016 | 10.36 Mn |
| Sep 30, 2016 | 8.39 Mn |